Key FDA committee unanimously recommends its first vaccine since 2023

Jun 19, 12:43 AM2 sources2 articlesEarly signalSettling in

Sources

NPRArs Technica

Last update

Jun 19, 12:43 AM

Published

Jun 19, 12:43 AM

Representative source

Coverage Timeline

Showing 2 English articles

Ars TechnicaJun 18, 10:08 PM

FDA advisors unanimously vote to approve Moderna's mRNA after agency drama

In February, a Trump official refused to review the vaccine.

NPRJun 19, 12:43 AM

Key FDA committee unanimously recommends its first vaccine since 2023

All nine members of the committee unanimously voted to recommend Moderna's new mRNA influenza vaccine for adults 50 and over.

HealthNeutral

Jun 19, 12:43 AM2 sources2 articlesEarly signalSettling in

Sources

NPRArs Technica

Last update

Jun 19, 12:43 AM

Published

Jun 19, 12:43 AM

Representative source

Coverage Timeline

Showing 2 English articles

Ars TechnicaJun 18, 10:08 PM

FDA advisors unanimously vote to approve Moderna's mRNA after agency drama

In February, a Trump official refused to review the vaccine.

NPRJun 19, 12:43 AM

Key FDA committee unanimously recommends its first vaccine since 2023

All nine members of the committee unanimously voted to recommend Moderna's new mRNA influenza vaccine for adults 50 and over.